Cargando…
Bcl-3 is a novel biomarker of renal fibrosis in chronic kidney disease
Progressive renal fibrosis in chronic kidney disease (CKD) greatly contributes to end-stage renal failure and is associated with high mortality. The identification of renal fibrosis biomarkers for the diagnosis and the monitoring of disease progression in CKD is urgently needed. Whole-transcriptomic...
Autores principales: | Chen, Ran, Wang, Lunshan, Liu, Sanhong, Chen, Xi, Hu, Yiming, Liu, Hanshao, Zhang, Haohao, Jiang, Yuhang, Wang, Qi, Ye, Deji, Li, Lingling, Liu, Dandan, Pan, Xiaorong, Wei, Lixin, Li, Xuemei, Zhang, Xiaoren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722556/ https://www.ncbi.nlm.nih.gov/pubmed/29228604 http://dx.doi.org/10.18632/oncotarget.21692 |
Ejemplares similares
-
Bcl-3 promotes TNF-induced hepatocyte apoptosis by regulating the deubiquitination of RIP1
por: Hu, Yiming, et al.
Publicado: (2021) -
Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin
por: Wang, Qi, et al.
Publicado: (2019) -
Bcl-3 promotes Wnt signaling by maintaining the acetylation of β-catenin at lysine 49 in colorectal cancer
por: Chen, Xi, et al.
Publicado: (2020) -
LncGMDS-AS1 promotes the tumorigenesis of colorectal cancer through HuR-STAT3/Wnt axis
por: Ye, Deji, et al.
Publicado: (2023) -
Serum RelB is correlated with renal fibrosis and predicts chronic kidney disease progression
por: Sun, Donglin, et al.
Publicado: (2021)